(Q44206837)
Statements
1 reference
Phase I-II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer (English)
1 reference
C Maulard
1 reference
P Richaud
1 reference
J P Droz
1 reference
D Jessueld
1 reference
F Dufour-Esquerré
1 reference
M Housset
1 reference
1 January 1995
1 reference
1 reference
36
1 reference
3
1 reference
259-262
1 reference
Identifiers
1 reference
1 reference